ArticleBMC cancer2023

Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial-a study protocol.

Yasmin A Civil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.